본문으로 건너뛰기

논문 검색

검색 결과 21,262 SQL fulltext 📄 CSV ↓ 📖 OA 100% 📄 PDF 20편
📖 출처 필터 (다중 토글 · 이 페이지 결과만)
📖 이 페이지: 20/20편 (100%) 무료 전문 가능 · 무료전문만 보기 →
  • Lenvatinib potentiates the antitumor efficacy of combined radiotherapy and PD-L1 blockade in lung adenocarcinoma.
    Cancer biology & therapy 2026 Liu Y 📖 Unpaywall CC BY 🆕 신규 PMID: 41481002 ↗

    [BACKGROUND] The potential of Lenvatinib to synergize with combined radiotherapy and immunotherapy in LUAD remains incompletely characterized. [METHODS] We investigated Lenvatinib's effects on radiation-induced PD-L1 in LUAD cells and VEGF…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • Spatial transcriptomics unveils immune cellular ecosystems associated with patient survival in diffuse large B-cell lymphoma.
    Oncoimmunology 2026 Diaz-Herrero A 📖 Unpaywall unknown 🆕 신규 PMID: 42010788 ↗

    Diffuse large B-cell Lymphoma (DLBCL) is the most prevalent subtype of non-Hodgkin's lymphoma for which current therapeutic strategies remain insufficient, in part owing to heterogeneity in tumor biology and the immune microenvironment. The…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • activates histone lactylation to promote gastric cancer progression and immune evasion through the HAS2/c-MYC/PD-L1 axis.
    Gut microbes 2026 Chen H 📖 Unpaywall unknown 🆕 신규 PMID: 42021123 ↗

    [BACKGROUND] Metabolic reprogramming and epigenetic alterations play important roles in driving tumor microenvironment (TME) remodeling and immune evasion in gastric cancer (GC). Histone lactylation links glycolytic metabolism to transcript…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • The distinct roles of and in proximal- and late-onset colorectal cancer.
    Gut microbes 2026 Ali S 📖 OA PDF 🆕 신규 PMID: 41947036 ↗

    Despite the emerging role of the gut microbiome in colorectal cancer (CRC), its significance in early-onset CRC (EOCRC, …

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • Downregulation of the lncRNA PGM5P4-AS1 predicts poor prognosis and drives breast cancer progression through miR-3664-5p/KLF9.
    Cancer biology & therapy 2026 Wu Y cited 1 🟢 PMC 🆕 신규 PMID: 41454916 ↗

    [BACKGROUND] Accumulating evidence suggests that deregulated long non-coding RNAs (lncRNAs) drive breast cancer (BRCA) progression. This study investigated the expression profile and mechanism of PGM5P4 antisense RNA 1 (PGM5P4-AS1) in BRCA.…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • Passive nuclear transport deviates from Fickian behavior in prostate and breast cell types.
    Nucleus (Austin, Tex.) 2026 Scott NR 🟢 PMC 🆕 신규 PMID: 41618797 ↗

    Nuclear trafficking is essential for cellular function and biomedical applications such as nucleus-targeted drug delivery; however, how passive nuclear transport varies across cell types and phenotypic states remains poorly understood. Here…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • The role of copper and cuproptosis in digestive system cancers: novel therapeutic strategies and mechanistic insights.
    Cancer biology & therapy 2026 Xu G 🟢 PMC 🆕 신규 PMID: 41837409 ↗

    Recent research has highlighted the critical role of copper metabolism and a novel form of copper-dependent cell death, termed cuproptosis, in the progression and treatment of these cancers. Copper, an essential trace element, plays a cruci…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • Dynamic changes in cellular mechanics and membrane microviscosity during migration of colorectal cancer cells.
    Cell cycle (Georgetown, Tex.) 2026 Shimolina L 🟢 PMC 🆕 신규 PMID: 41532524 ↗

    The ability of tumor cells to migrate and invade adjacent tissue is a key property underlying the metastatic process. To ensure greater deformability and to facilitate movement, migratory cells undergo multiple changes in biophysical parame…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • The interplay between autophagy, p16, and senescence in tumor cells: a systematic review.
    Cell cycle (Georgetown, Tex.) 2026 Palabiyik AA 🟢 PMC 🆕 신규 PMID: 41317088 ↗ 메타분석

    Autophagy and cellular senescence are fundamental determinants of tumor cell fate. p16 has emerged as a key regulator at the intersection of these processes, yet its mechanistic role in the autophagy - senescence axis remains incompletely d…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • Adding anti-PD-1 antibody to definitive chemoradiotherapy in elderly patients with esophageal squamous cell carcinoma: higher intensity does not equate to better outcomes.
    Annals of medicine 2026 Cen P 📖 Unpaywall unknown 🆕 신규 PMID: 41626750 ↗

    [BACKGROUND AND PURPOSE] The benefit of adding anti-PD-1 antibodies to definitive chemoradiotherapy (dCRT) in elderly patients with esophageal squamous cell carcinoma (ESCC) remains uncertain. This study evaluated its efficacy and safety ve…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • Economic evaluation of perioperative pembrolizumab plus standard of care as treatment for resectable locally advanced head and neck squamous cell carcinoma in the United States.
    Journal of medical economics 2026 Qian F 📖 Unpaywall unknown 🆕 신규 PMID: 41730003 ↗

    [AIMS] In the phase 3 KEYNOTE-689 trial (NCT03765918) among patients with resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC), perioperative pembrolizumab (pembrolizumab before surgery, then continued with standard-…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • Cost-per-responder analysis of TAR-200 versus other Food and Drug Administration-approved novel and generic treatments among patients with Bacillus Calmette-Guérin-unresponsive, high-risk, non-muscle-invasive bladder cancer with carcinoma in situ in the United States.
    Journal of medical economics 2026 Williams S 📖 Unpaywall unknown 🆕 신규 PMID: 42012856 ↗

    [AIMS] Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (HR-NMIBC) with carcinoma (CIS) is aggressive and treatment options are suboptimal. TAR-200, a novel intravesical drug-releasing system, receiv…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • A real-world study evaluating drug tolerability and health care resource use with acalabrutinib vs ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Journal of medical economics 2026 Dranitsaris G 📖 Unpaywall unknown 🆕 신규 PMID: 41454883 ↗

    [BACKGROUND AND AIM] Bruton tyrosine kinase inhibitors (BTKis) are the standard of care for patients with relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Ibrutinib and acalabrutinib are two commo…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • Prolonged progression-free survival with zanubrutinib in relapsed/refractory CLL: an indirect treatment comparison versus other BTK inhibitors using multilevel network meta-regression.
    Journal of medical economics 2026 Shadman M 📖 Unpaywall unknown 🆕 신규 PMID: 41553230 ↗

    [BACKGROUND] Bruton tyrosine kinase inhibitors (BTKis) are therapeutic agents for relapsed/refractory chronic lymphocytic leukemia (R/R CLL). Previous indirect treatment comparisons are limited in simultaneously comparing multiple intervent…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • XPO1 Inhibition enhances sensitivity to platinum-based chemotherapy in germinal-center B-cell-like-DLBCL cells.
    Hematology (Amsterdam, Netherlands) 2026 Su Q 📖 Unpaywall unknown 🆕 신규 PMID: 41631406 ↗

    [PURPOSE] Platinum-based chemotherapy is considered as salvage therapy to relapsed/refractory diffuse large B-cell lymphoma (DLBCL) patients. However, treatment failure due to drug resistance occurs in some patients, particularly those with…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • Phase angle as a nutritional assessment method in patients with acute myeloid leukemia: a cross-sectional study.
    Hematology (Amsterdam, Netherlands) 2026 Li W 📖 Unpaywall CC BY 🆕 신규 PMID: 41701098 ↗ 단면연구

    [BACKGROUND AND OBJECTIVES] The phase angle, which is associated with cellular health, has garnered increasing attention as a noninvasive and objective method for nutritional assessment. However, the association between malnutrition and pha…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • The surgery for the patients with intestinal non‑Hodgkin lymphomas: a nationwide study.
    Annals of medicine 2026 Kim J 📖 Unpaywall CC BY 🆕 신규 PMID: 41732903 ↗

    [BACKGROUND] The treatment strategy for intestinal non-Hodgkin lymphoma (NHL) and the role of surgery warrant reevaluation. [METHODS] This study analyzed clinical data from a cohort of 12,047 patients diagnosed with intestinal NHL, extract…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • NAD precursor supplementation reverses CD36-mediated lipid accumulation and ferroptosis to restore antitumor function of NK cells in DLBCL.
    Pharmaceutical science advances 2026 Shi L 📖 Unpaywall CC BY-NC-ND 🆕 신규 PMID: 41993707 ↗

    Natural killer (NK) cells play a key role in the standard treatment of diffuse large B-cell lymphoma (DLBCL). However, NK cells in DLBCL patients frequently display an exhausted phenotype, which is associated with poor clinical outcomes. Th…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • A Randomized Trial Evaluating Intraoperative Ischemic Preconditioning of Parathyroid Glands During Total Thyroidectomy: A Signal for Earlier Parathyroid Function Recovery.
    Journal of investigative surgery : the official journal of the Academy of Surgical Research 2026 Sheng Q 📖 Unpaywall unknown 🆕 신규 PMID: 41612903 ↗ 무작위 임상시험

    [BACKGROUND] Ischemic preconditioning of parathyroid glands (IPCP) is biologically plausible but clinical evidence is limited. In this single-center randomized trial (ChiCTR2000039788), we compared IPCP versus control during total thyroidec…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus
  • Integrating virtual screening and molecular dynamics simulations to identify emodin as a PYCR1 inhibitor modulating docetaxel sensitivity in prostate cancer.
    Journal of enzyme inhibition and medicinal chemistry 2026 Liu S 📖 Unpaywall unknown 🆕 신규 PMID: 41665114 ↗

    Docetaxel (DTX) resistance is the main cause of treatment failure in castration-resistant prostate cancer (CRPC). Pyrroline-5-carboxylic acid reductase 1 (PYCR1) is an enzyme involved in proline metabolism. It is highly expressed in various…

    FULLTEXT: Cellular Reprogramming randomized randomized randomized versus